Log In

Resource Explorer

Help

FUNDING CANCER - Toward Translation of Nanotechnology Cancer Interventions (R01 Clinical Trial Not Allowed)

Visit Website Add to Calendar 2025-01-06T05:00:00 2027-11-16T04:59:00 FUNDING CANCER - Toward Translation of Nanotechnology Cancer Interventions (R01 Clinical Trial Not Allowed)<p><strong>Sponsor:</strong> NIH</p> <p><strong>Description:</strong> This funding opportunity is designed to enable the translation of nanotechnology-based cancer interventions relying on nanoparticle formulations and/or nano-devices. Through the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) initiative, the NCI encourages applications for advanced pre-clinical research, translation of nanotechnology-based cancer diagnostics, and therapeutics. TTNCI awards are expected to mature experimental nanomedicines designed for highly relevant cancer clinical objectives with a strong potential to improve cancer treatment effectiveness.</p> <ul> <li><strong>Applications Due:</strong><ul> <li>May 19, 2025</li> <li>November 17, 2025</li> <li>May 18, 2026</li> <li>November 16, 2026</li> <li>May 17, 2027</li> <li>November 15, 2027</li> </ul> </li> </ul> <p>To view all current UVACCC funding opportunities, please click <a href="https://uvacancercenter.infoready4.com/" target="_blank">here.</a></p> <p>For all open cancer-related funding opportunities, please click <a href="https://portal.ithriv.org/#/search/filter?query=Cancer&showPastEvents=false&Type=Funding%20Resource">here.</a></p>OnlineUTC
Location: Online
January 6, 2025 5:00 AM UTC – November 16, 2027 4:59 AM UTC

Sponsor: NIH

Description: This funding opportunity is designed to enable the translation of nanotechnology-based cancer interventions relying on nanoparticle formulations and/or nano-devices. Through the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) initiative, the NCI encourages applications for advanced pre-clinical research, translation of nanotechnology-based cancer diagnostics, and therapeutics. TTNCI awards are expected to mature experimental nanomedicines designed for highly relevant cancer clinical objectives with a strong potential to improve cancer treatment effectiveness.

  • Applications Due:
    • May 19, 2025
    • November 17, 2025
    • May 18, 2026
    • November 16, 2026
    • May 17, 2027
    • November 15, 2027

To view all current UVACCC funding opportunities, please click here.

For all open cancer-related funding opportunities, please click here.

Creator Organization University of Virginia
Categories
PROPOSE > FUNDING RESOURCES > Federal and State Funding
Website https://grants.nih.gov/grants/guide/pa-files/PAR-25-336.html

Attachments

There are no files to display.